SESANA MARIA SILVIA

La Rosa, F., Agostini, S., Bolognesi, E., Marventano, I., Mancuso, R., Guerini, F., et al. (2025). Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer’s Disease Model—A Novel Potential Therapy for Neuroinflammation: A Pilot Study. BIOMOLECULES, 15(8) [10.3390/biom15081074]. Dettaglio

Sica, F., Patrucco, M., Giambra, M., Ghizzi, M., Sesana, S., Vergani, B., et al. (2025). Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-21272-3]. Dettaglio

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio

Sierri, G., Patrucco, M., Ferrario, D., Renda, A., Comi, S., Ciprandi, M., et al. (2024). Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY, 16(5 (September/October 2024)) [10.1002/wnan.1991]. Dettaglio

Shaik, M., Pasco, S., Romerio, A., Pifferi, C., Sesana, S., Re, F., et al. (2024). Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant. JOURNAL OF MEDICINAL CHEMISTRY, 67(24), 22254-22262 [10.1021/acs.jmedchem.4c02392]. Dettaglio